Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 22;163(3):545-8.
doi: 10.1016/j.cell.2015.10.004. Epub 2015 Oct 22.

Germinal center selection and the antibody response to influenza

Affiliations
Review

Germinal center selection and the antibody response to influenza

Gabriel D Victora et al. Cell. .

Abstract

In this Minireview, we discuss basic aspects of germinal center biology in the context of immunity to influenza infection and speculate on how the simultaneous evolutionary races of virus and antibody may impact our efforts to design a universal influenza vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Residue conservation among seasonal H1 HA isolates (1975–2005). Conservation is shown for one monomer, on a scale from blue (most conserved) to white (most variable). Red residues indicate common glycosylation sites. The RBS is marked with a star. Image courtesy of Stephen C. Harrison. (B) Overview of affinity maturation in the GC. Cyclic migration of B cells between light and dark zones drives affinity maturation. Prior to GC entry and upon positive selection, B cells can differentiate into the PC or memory fates. (C) Proposed model for reestablishment of immunodominance to strain-specific epitopes. Top, exposure to Strain 1 of influenza generates a response mostly focused on immunodominant, Strain 1-specific epitopes (red), but also induces a subdominant crossreactive response (green). Middle, exposure to a divergent Strain 2 will initially reactivate cross-reactive memory cells (green) from the response to Strain 1, generating a “broad” response, but will also prime Strain 2-specific clones de novo, which will eventually outcompete the crossreactive clones. Bottom, re-exposure to Strain 2 will preferentially recall Strain 2-specific clones, reinstating immunodominance.

References

    1. Del Giudice G, Rappuoli R. Curr Top Microbiol Immunol. 2015;386:151–180. - PubMed
    1. Eisen HN. Cancer Immunol Res. 2014;2:381–392. - PubMed
    1. Ellebedy AH, Krammer F, Li GM, Miller MS, Chiu C, Wrammert J, Chang CY, Davis CW, McCausland M, Elbein R, et al. PNAS. 2014;111:13133–13138. - PMC - PubMed
    1. Espeli M, Clatworthy MR, Bokers S, Lawlor KE, Cutler AJ, Kontgen F, Lyons PA, Smith KG. The Journal of experimental medicine. 2012;209:2307–2319. - PMC - PubMed
    1. Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R. Nat Immunol. 2010;11:681–688. - PubMed

Publication types

Substances